XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Restricted Stock [Member]
Common Stock
Additional Paid-in Capital
Employee Stock Option [Member]
[1]
Additional Paid-in Capital
Restricted Stock [Member]
[1]
Additional Paid-in Capital
[1]
Accumulated Deficit
Total Precipio, Inc.
Employee Stock Option [Member]
Total Precipio, Inc.
Restricted Stock [Member]
Total Precipio, Inc.
Noncontrolling Interest in Joint Venture
Employee Stock Option [Member]
Restricted Stock [Member]
Total
Balance at beginning of period at Dec. 31, 2022     $ 11 [1]     $ 108,588 $ (92,297)     $ 16,302 $ 65     $ 16,367
Balance at beginning of period (in shares) at Dec. 31, 2022 47   1,141,013 [1]                      
Increase (Decrease) in Stockholders' Equity                            
Net loss             (5,853)     (5,853)       (5,853)
Gain on dissolution of joint venture                     $ (65)     (65)
Issuance of common stock in connection with purchase agreements     $ 2 [1]     1,758       1,760       1,760
Issuance of common stock in connection with purchase agreements (in shares) [1]     206,250                      
Issuance of common stock in connection with at the market offering, net of issuance costs     $ 1 [1]     484       485       485
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares) [1]     30,852                      
Proceeds upon issuance of common stock from exercise of warrants (in shares) [1]     15,972                      
Issuance of common stock for consulting services           177       177       177
Issuance of common stock for consulting services (in shares) [1]     23,598                      
Stock-based compensation         $ 16 1,542     $ 16 1,542     $ 16 1,542
Stock-based compensation (in shares) [1]   2,492                        
Payment of fractional common shares in conjunction with reverse stock split (in shares) [1]     (52)                      
Balance at end of period at Dec. 31, 2023     $ 14 [1]     112,565 (98,150)     14,429       14,429
Balance at end of period (in shares) at Dec. 31, 2023 47   1,420,125 [1]                      
Increase (Decrease) in Stockholders' Equity                            
Net loss             (4,290)     (4,290)       (4,290)
Issuance of common stock in connection with at the market offering, net of issuance costs           78       78       78
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares) [1]     11,822                      
Issuance of common stock for consulting services     $ 1 [1]     385       386       386
Issuance of common stock for consulting services (in shares) [1]     61,692                      
Stock-based compensation       $ 1,491       $ 1,491       $ 1,491    
Balance at end of period at Dec. 31, 2024     $ 15 [1]     $ 114,519 $ (102,440)     $ 12,094       $ 12,094
Balance at end of period (in shares) at Dec. 31, 2024 47   1,493,639 [1]                      
[1] The common stock and additional paid-in capital for all periods presented reflect the one-for-twenty reverse stock split, which was effected on September 21, 2023.